DUBLIN, Calif.--(BUSINESS WIRE)--SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., chairman and chief executive officer, and Harren Jhoti, Ph.D., president, will present at the Rodman & Renshaw 13th Annual Healthcare Conference on Monday, September 12th in New York as Astex Pharmaceuticals, Inc., subject to final legal and NASDAQ listing approvals.
